Perioperative Risk Factors of Outcomes for Cardiac Surgery: A Retrospective Study
1 other identifier
observational
3,000
1 country
1
Brief Summary
Based on a review of about 10,000 patients undergoing cardiac surgery under CPB in West China Hospital of Sichuan University and the Second Affiliated Hospital of Zhejiang University, we try to evalute the effect of blood transfusion on outcomes in cardiac surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2017
CompletedFirst Submitted
Initial submission to the registry
August 23, 2020
CompletedFirst Posted
Study publicly available on registry
July 28, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2021
CompletedJuly 28, 2021
August 1, 2020
4.5 years
August 23, 2020
July 19, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
mortality
all-cause death
28 days after surgery
Interventions
acute normovolemic hemodilution
Eligibility Criteria
The patients in the west China hospital of sichuan university (July 01, 2011, solstice during June 30, 2017) and the second affiliated hospital of zhejiang university (September 01, 2013, solstice, June 30, 2017) have cardiac surgery under Cardiopulmonary bypass (CPB)
You may qualify if:
- The patients in the west China hospital of sichuan university (July 01, 2011, solstice during June 30, 2017) and the second affiliated hospital of zhejiang university (September 01, 2013, solstice, June 30, 2017) have cardiac surgery under Cardiopulmonary bypass (CPB)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
ANH
Hangzhou, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Min Yan, doctor
The Second Affiliated Hospital of Zhejiang University Medical College
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
August 23, 2020
First Posted
July 28, 2021
Study Start
July 1, 2017
Primary Completion
December 31, 2021
Study Completion
December 31, 2021
Last Updated
July 28, 2021
Record last verified: 2020-08